Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,657,855
+$5,296,985 QoQ
Shares Held
44,030
+1367.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#991
of 3,778 holders
Holding Since
Sep 2020
11 quarters on record
Voting authority
Sole 91%
Shared 9%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Derivatives in MRK
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$2,570,000
PutShares
20,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LMR Partners LLP holds $144,798,606 across 13 Drug Manufacturers - General names. MRK ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
|
980,479 | $51,396,709 | |
| 2 | NVS |
Novartis AG
|
153,726 | $24,091,938 | |
| 3 | ABBV |
AbbVie Inc.
|
79,736 | $20,064,766 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
330,151 | $19,023,300 | |
| 5 | PFE |
Pfizer Inc
|
260,990 | $6,284,639 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
44,030 | $5,657,855 | |
| 7 | OGN |
Organon & Co.
|
396,842 | $5,373,240 | |
| 8 | LLY |
ELI LILLY & Co
|
3,390 | $4,066,066 |
All Filings in MRK
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,570,000 | 20,000 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $5,657,855 | 44,030 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $4,931,890 | 41,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $360,870 | 3,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,157,800 | 30,000 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $1,345,951 | 14,995 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,492,200 | 15,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $1,491,702 | 14,995 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,702,832 | 14,995 | Shares | Sole | 2024-11-07 | |
| 2024-09-30 | $1,703,400 | 15,000 | Call | Sole | 2024-11-07 | |
| 2024-03-31 | $1,224,232 | 9,278 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $1,466,426 | 13,217 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,984,600 | 46,268 | Shares | Sole | 2022-11-14 | |
| 2020-12-31 | $270,921 | 3,312 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,282,490 | 15,461 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||